STAT

Get ready for STAT Madness 2018

STAT Madness is fundamentally a celebration of science. It starts Monday.

What does great biomedical science look like? Is it an advance in cancer therapy? A device that helps people recover from injury faster? Or, is it an inexpensive tool that gives developing nations a chance to fight crippling disease?

Great bioscience looks like all of this, and those examples are among the nearly 150 entries you sent us for STAT Madness, our yearly contest to find the next best innovations in health and medicine.

Starting Monday, we’ll seed a single-elimination bracket of 64 entries that will give us a crowd-voted favorite. (Click for last year’s

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related Books & Audiobooks